Europe Archives | Surviving Mesothelioma

Age May Have Little Impact on Mesothelioma Surgery Outcomes

Being older does not necessarily reduce a patient’s odds of benefiting from mesothelioma surgery. That is the good news from a study conducted by mesothelioma experts at Glenfield Hospital in Leicester, England. The bad news is that too many elderly mesothelioma patients are not being referred for adjuvant treatments that could improve their surgical outcomes. Adjuvant Therapy and Mesothelioma Survival Adjuvant therapy is a treatment … Continue reading Age May Have Little Impact on Mesothelioma Surgery Outcomes »

New Assessment Identifies People at High Risk for Malignant Mesothelioma

Black American Patient

Scottish researchers say they have come up with a better way to decide which asbestos-exposed people might benefit from mesothelioma screening or even mesothelioma prevention measures. They have developed an assessment tool to gather detailed information from workers about the time, duration, and nature of their asbestos exposure in order to better quantify their mesothelioma risk. “The assessment is based on the tasks carried out … Continue reading New Assessment Identifies People at High Risk for Malignant Mesothelioma »

New Chemotherapy Technique Carries Risks for Peritoneal Mesothelioma Patients

A new way of delivering chemotherapy drugs to the site of a peritoneal mesothelioma tumor has some unique benefits, but can also be risky. The technique, called pressurized intraperitoneal aerosol chemotherapy (PIPAC) allows doctors to “spray” a solution of chemotherapy drugs directly onto peritoneal tumors through small ports in the abdomen. The intention is to uniformly coat the tumor and help keep chemotherapy drugs in … Continue reading New Chemotherapy Technique Carries Risks for Peritoneal Mesothelioma Patients »

Mesothelioma Patients May Benefit from ‘Aesthetic Support’

When it comes to coping with the treatment and side effects of a cancer like malignant mesothelioma, looks matter – especially to female patients. That is the message of a new Italian study on the impact of an “aesthetic care” program for hospitalized cancer patients. The objective of the study, published in the journal Frontiers in Psychology, was to evaluate a support program called “Health … Continue reading Mesothelioma Patients May Benefit from ‘Aesthetic Support’ »

New Biomarker Could Help Eradicate Mesothelioma Resistance to Chemotherapy

Researchers in the Netherlands have unveiled what may be a major breakthrough in the chemotherapeutic treatment of malignant mesothelioma. Malignant mesothelioma, a rare and virulent cancer caused by asbestos exposure, is notoriously resistant to standard cancer treatments, including chemotherapy. Even the only chemotherapy drug specifically approved for the treatment of mesothelioma, Alimta (pemetrexed), only works for some patients. Now, a new study published in the … Continue reading New Biomarker Could Help Eradicate Mesothelioma Resistance to Chemotherapy »

Curcumin Shrinks Aggressive Mesothelioma Tumors in New Study

The bright yellow chemical that gives turmeric its spicy kick has scored yet another win as a possible treatment for malignant mesothelioma. This time, scientists used it on lab rats to successfully shrink one of the most aggressive types of mesothelioma tumors. The plant polyphenol curcumin has been the subject of numerous malignant mesothelioma studies in recent years, in part because of its powerful anti-inflammatory properties. Curcumin as … Continue reading Curcumin Shrinks Aggressive Mesothelioma Tumors in New Study »

New Chemotherapy Booster May Extend Mesothelioma Survival

Cancer researchers say the VEGF-inhibitor nintedanib (Ofev) extended mesothelioma survival by more than five months in patients on standard chemotherapy in a new trial. That is among the findings of a recently-published Phase II study of nintedanib as an adjunct therapy to pemetrexed (Alimta) and cisplatin for malignant pleural mesothelioma. Nintedanib Trial Details Nintedanib is currently used to treat idiopathic pulmonary fibrosis and some types … Continue reading New Chemotherapy Booster May Extend Mesothelioma Survival »

Fluid Drainage Brings Symptom Relief for Mesothelioma Patients

The majority of mesothelioma patients polled say they could breathe easier after a procedure to remove excess lung fluid from their chest. The more fluid that was removed, the better they felt. Those findings come from a new UK study of patient-reported outcome measures among 158 people suffering from malignant pleural mesothelioma. Collecting Data from Mesothelioma Patients The data that formed the basis of the … Continue reading Fluid Drainage Brings Symptom Relief for Mesothelioma Patients »

Preventing and Treating Mesothelioma with Phytochemicals

Italian scientists say it may one day be possible to treat or even prevent malignant mesothelioma by harnessing the powerful phytochemicals in fruits and vegetables. Malignant mesothelioma is the most deadly of the diseases linked to asbestos exposure. There is no cure and standard cancer therapies are rarely able to stop its progression for long. But, in a new report published in the October 2017 … Continue reading Preventing and Treating Mesothelioma with Phytochemicals »

Second Study Confirms Pleural Mesothelioma Risk Plateau

Another new study has confirmed the idea that pleural mesothelioma risk does not appear to increase indefinitely after asbestos exposure, but instead may eventually hit a plateau. The newest study involved more than 1,800 asbestos cement workers in Pavia, Italy. Researchers in the department of public health at the University of Pavia and the University Eastern Piedmont in Novara computed the mortality ratios for the … Continue reading Second Study Confirms Pleural Mesothelioma Risk Plateau »

Get your free copy of
“Surviving Mesothelioma” Today!